These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38078373)

  • 21. Oral isotretinoin for acne.
    Costa CS; Bagatin E; Martimbianco ALC; da Silva EM; Lúcio MM; Magin P; Riera R
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009435. PubMed ID: 30484286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a facial serum and a mask containing salicylic acid and lipohydroxy acid in acne management: A randomized controlled trial.
    Li S; He X; Zhang Z; Zhang XS; Niu YG; Steel A; Wang HT
    J Cosmet Dermatol; 2023 Sep; 22(9):2502-2511. PubMed ID: 36999489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials.
    Tanghetti EA; Werschler WP; Lain T; Guenin E; Martin G; Pillai R
    J Drugs Dermatol; 2020 Jan; 19(1):70-77. PubMed ID: 31985914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical tazarotene cream (0.1%) in the treatment of facial acne: an open clinical trial.
    Zakaria AS; Paul HK; Rahman MA; Islam MT; Choudhury AM
    Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):43-6. PubMed ID: 21473199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.
    Blume-Peytavi U; Fowler J; Kemény L; Draelos Z; Cook-Bolden F; Dirschka T; Eichenfield L; Graeber M; Ahmad F; Alió Saenz A; Rich P; Tanghetti E
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):166-173. PubMed ID: 31306527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women.
    Lynde CW; Andriessen A
    Skinmed; 2014; 12(1):15-21. PubMed ID: 24720080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
    Feldman SR; Werner CP; Alió Saenz AB
    J Drugs Dermatol; 2013 Apr; 12(4):438-46. PubMed ID: 23652892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
    Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
    Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial.
    Woolery-Lloyd H; Baumann L; Ikeno H
    J Cosmet Dermatol; 2010 Mar; 9(1):22-7. PubMed ID: 20367669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. UV-selective face cream (Acne RA-1,2) in acne patients: clinical study of its effects on epidermal barrier function, sebum production, tolerability and therapy adherence.
    Monfrecola G; Capasso C; Russo G; Fabbrocini G
    G Ital Dermatol Venereol; 2018 Feb; 153(1):26-32. PubMed ID: 27284780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the efficacy and safety of a combination of 2 topical retinoids (RetinSphere) in maintaining post-treatment response of acne to oral isotretinoin.
    Truchuelo MT; Jiménez N; Mavura D; Jaén P
    Actas Dermosifiliogr; 2015 Mar; 106(2):126-32. PubMed ID: 25306870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
    Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
    J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of calcipotriol as a potential topical treatment of acne vulgaris: a randomized, controlled, triple blinded, split-face clinical trial.
    Mahran A; Ghazally A; Ali AS; Bakr RM
    Clin Exp Dermatol; 2024 Mar; 49(4):348-355. PubMed ID: 37925677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
    Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined oral contraceptive pills for treatment of acne.
    Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD004425. PubMed ID: 22786490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined oral contraceptive pills for treatment of acne.
    Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
    Cochrane Database Syst Rev; 2012 Jun; (6):CD004425. PubMed ID: 22696343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
    Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
    J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Efficacy and Safety of Azelaic Acid 15% Foam in the Treatment of Truncal Acne Vulgaris.
    Hoffman LK; Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2017 Jun; 16(6):534-538. PubMed ID: 28686770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial.
    Dreno B; Tan J; Rivier M; Martel P; Bissonnette R
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):737-742. PubMed ID: 27790756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.